A Phase 2 Study Using Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Advanced Leiomyosarcoma
Condition: Leiomyosarcoma Intervention: Drug: Trabectedin Sponsor: Sarcoma Oncology Research Center, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2020 Category: Research Source Type: clinical trials
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
Condition: Leiomyosarcoma Intervention: Drug: Trabectedin Sponsor: Sarcoma Oncology Research Center, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2020 Category: Research Source Type: clinical trials